NASDAQ : GRCE

Grace Therapeutics, Inc. — Insider Trades

$2.43 USD

$0 (0.0%)

Volume
94.29K
Average Volume
520.58K
Market Capitalization
$39.55M
P/E Ratio
-4.37
Dividend Yield
0.00%
Price Target
$4.00
Year High
$5.18
Year Low
$1.79
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.10
Insider Activity Summary (Last 12 Months)
Insiders Buying

0

Insiders Selling

0

Amount of Insider Selling

-$

GRCE Insider Buying/Selling by Quarter
GRCE Insider Trading History
Insider Name Title Date Transaction Cost Filing Date
Kavuru Vimal director 2026-01-08 A-Award 3.8 2026-01-12
Kottayil George director 2026-01-08 A-Award 3.8 2026-01-12
NEUGEBOREN EDWARD director 2026-01-08 A-Award 3.8 2026-01-12
DAVIS A BRIAN director 2026-01-08 A-Award 3.8 2026-01-12
Kottayil George director 2025-05-09 A-Award 2.72 2025-05-13
NEUGEBOREN EDWARD director 2025-05-09 A-Award 2.72 2025-05-13
DAVIS A BRIAN director 2025-05-09 A-Award 2.72 2025-05-13
Kavuru Vimal director 2025-05-09 A-Award 2.72 2025-05-13
Kumar Amresh officer: VP Program Management 2025-04-14 A-Award 2.08 2025-04-16
Macdonald R. Loch officer: Chief Medical Officer 2025-04-14 A-Award 2.08 2025-04-16
DelAversano Robert J officer: Principal Financial Officer 2025-04-14 A-Award 2.08 2025-04-16
Kohli Prashant director, officer: Chief Executive Officer 2025-04-14 A-Award 2.08 2025-04-16
D'Andrea Carrie officer: VP Clinical Operations 2025-04-14 A-Award 2.08 2025-04-16